Concepedia

Stanley R. Howell

SR

Statistics

Publications

15

Citations

543

H-Index

12

Active since

1983

Affiliations

Ligand Pharmaceuticals (United States)(Current)

University of Kansas Medical Center

Women's Health Research Institute

Stanley R. Howell is an author at Ligand Pharmaceuticals (United States) specializing in pharmacology, biochemistry, and life sciences.

Publications per year

1983–2006

15

Publications

15

Metabolic disposition of<sup>14</sup>C-venlafaxine in mouse, rat, dog, rhesus monkey and man

Stanley R. Howell, G. E. M. Husbands, JoAnn Scatina et al. · Xenobiotica · 1993 · 122 citations

, , +13

The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine

C. Paul Wang, Stanley R. Howell, JoAnn Scatina et al. · Chirality · 1992 · 59 citations

, , +11

Pharmacokinetics of venlafaxine and<i>O</i>-desmethylvenlafaxine in laboratory animals

Stanley R. Howell, David Hicks, JoAnn Scatina et al. · Xenobiotica · 1994 · 50 citations

, , +12

Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.

Stanley R. Howell, Michael A. Shirley, E H Ulm · PubMed · 1998 · 50 citations

, , +12

Retinoid X Receptor Acts as a Hormone Receptor in Vivo to Induce a Key Metabolic Enzyme for 1,25-Dihydroxyvitamin D3

Elizabeth A. Allegretto, Nirupama K. Shevde, Aihua Zou et al. · Journal of Biological Chemistry · 1995 · 49 citations · Full text

, , +17

1–5 of 15